StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Orchid Pharma Limited
NSE:ORCHPHARMA.NS
Sector
Location
Market Cap
USD 424.30 M
Share Price
USD 8.19
Avg Daily Volume
140,881
Change (1 day)
-0.60%
Change (1 year)
-49.98%
Change (YTD)
-61.22%
Orchid Pharma Limited Return on Assets (ROA) for the year ending March 31, 2025: 5.90%
Orchid Pharma Limited Return on Assets (ROA) is 5.90% for the year ending March 31, 2025, a -0.46% change year over year. Return on assets measures profitability against assets; higher ROA indicates efficient asset use and profitability.
-
Orchid Pharma Limited Return on Assets (ROA) for the year ending March 31, 2024 was 5.93%, a 56.90% change year over year.
-
Orchid Pharma Limited Return on Assets (ROA) for the year ending March 31, 2023 was 3.78%, a -2,251.71% change year over year.
-
Orchid Pharma Limited Return on Assets (ROA) for the year ending March 31, 2022 was -0.18%, a -98.13% change year over year.
-
Orchid Pharma Limited Return on Assets (ROA) for the year ending March 31, 2021 was -9.42%, a 4.91% change year over year.
Competitors
Eli Lilly and Company
USD 805.43
LLY
+6.54
0.82%
AbbVie Inc.
USD 190.83
ABBV
+0.28
0.15%
Roche Holding AG
USD 352.25
RO.SW
+3.41
0.98%
AstraZeneca PLC
USD 147.28
AZN.L
+2.35
1.62%
Merck & Co., Inc.
USD 84.11
MRK
+0.13
0.15%
Amgen Inc.
USD 308.55
AMGN
-0.67
-0.22%
Pfizer Inc.
USD 25.35
PFE
-0.01
-0.04%
Gilead Sciences, Inc.
USD 113.20
GILD
-0.36
-0.32%
Sanofi
USD 100.09
SAN.PA
+0.48
0.48%
Bristol-Myers Squibb Company
USD 48.94
BMY
-0.04
-0.08%
Chugai Pharmaceutical Co., Ltd.
USD 49.80
4519.T
+0.60
1.22%
GSK plc
USD 18.78
GSK.L
+0.16
0.83%
Regeneron Pharmaceuticals, Inc.
USD 564.64
REGN
-7.75
-1.35%
Cencora, Inc.
USD 290.45
COR
-2.99
-1.02%
Jiangsu Hengrui Medicine Co., Ltd.
USD 8.04
600276.SS
+0.06
0.73%
Takeda Pharmaceutical Company Limited
USD 29.42
4502.T
-0.15
-0.50%
Daiichi Sankyo Company, Limited
USD 24.62
4568.T
-0.30
-1.21%
Haleon plc
USD 4.93
HLN.L
+0.06
1.26%
Ucb S.A.
USD 210.11
UCB.BR
+0.83
0.40%
BeOne Medicines Ltd.
USD 296.46
ONC
+1.63
0.55%
Key Data
| Date | Return on Assets (ROA) | Revenue Per Share | Free Cash Flow Per Share | Dividend Per Share |
|---|
Competitors
Eli Lilly and Company
USD 805.43
LLY
+6.54
0.82%
AbbVie Inc.
USD 190.83
ABBV
+0.28
0.15%
Roche Holding AG
USD 352.25
RO.SW
+3.41
0.98%
AstraZeneca PLC
USD 147.28
AZN.L
+2.35
1.62%
Merck & Co., Inc.
USD 84.11
MRK
+0.13
0.15%
Amgen Inc.
USD 308.55
AMGN
-0.67
-0.22%
Pfizer Inc.
USD 25.35
PFE
-0.01
-0.04%
Gilead Sciences, Inc.
USD 113.20
GILD
-0.36
-0.32%
Sanofi
USD 100.09
SAN.PA
+0.48
0.48%
Bristol-Myers Squibb Company
USD 48.94
BMY
-0.04
-0.08%
Chugai Pharmaceutical Co., Ltd.
USD 49.80
4519.T
+0.60
1.22%
GSK plc
USD 18.78
GSK.L
+0.16
0.83%
Regeneron Pharmaceuticals, Inc.
USD 564.64
REGN
-7.75
-1.35%
Cencora, Inc.
USD 290.45
COR
-2.99
-1.02%
Jiangsu Hengrui Medicine Co., Ltd.
USD 8.04
600276.SS
+0.06
0.73%
Takeda Pharmaceutical Company Limited
USD 29.42
4502.T
-0.15
-0.50%
Daiichi Sankyo Company, Limited
USD 24.62
4568.T
-0.30
-1.21%
Haleon plc
USD 4.93
HLN.L
+0.06
1.26%
Ucb S.A.
USD 210.11
UCB.BR
+0.83
0.40%
BeOne Medicines Ltd.
USD 296.46
ONC
+1.63
0.55%